thanks MarsC.
appreciate your optimism. I sincerely hope you are right - You and Dr Holmes are better informed than me. I'm still a little sceptical, but very happy if this turns out to be a great success.
My unanswered question (a new one) is why do ONT want to distribute Oventus's product and not FPHs or Resmeds? or are they distributing those already ? Why not distribute the existing new/proven technology?
any further thoughts appreciated
ONT Price at posting:
$7.62 Sentiment: Hold Disclosure: Held